findmyKOL
Clinical trialNCT05794958RecruitingPhase 1Interventional

Evaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-Cel

SponsorStanford UniversityEnrollment20Large B-cell LymphomaNon-Hodgkin Lymphoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a phase Ib study to establish safety of Axi-Cel-2 in patients with Large B Cell Lymphoma (LBCL) who are at high risk of relapse.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Stanford University

    Palo Alto, California, United States

    Andrew Rezvani, MDDavid B. Miklos, MD, PhDEverett Meyer, MD, PhDJudith Shizuru, MD, PhDLaura Johnston, MDLori Muffly, MD, MSMatthew Frank, MD, PhDMelody Smith, MDPraveen Shiraz, MDRobert Lowsky, MDRobert Negrin, MDSally Arai, MDSurbhi Sidana, MDWen-Kai Weng, MD, PhD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Axicabtagene ciloleucel →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
23 May 2023
Primary completion
1 Apr 2038
Completion
1 Apr 2038
Last update posted
23 Sept 2025
Registered enrollment
20
Registry id
NCT05794958
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.